#FEBS
The tryptophan prenyltransferase ComQ from Bacillus subtilis 168 can prenylate daptomycin at Trp1 febs.onlinelibrary.wiley.com/doi/full/10....
FEBS Press
ComQ168 from Bacillus subtilis 168 catalyzes C-terminal tryptophan farnesylation of ComX to generate a competence-inducing pheromone. Recombinant ComQ168 also modifies cyclic peptides, including Dapt...
febs.onlinelibrary.wiley.com
November 4, 2026 at 12:01 PM
The authors included RRIDs in their in FEBS Letters paper! Thanks for making your methods matter! #STMpublishing #ReproducibleResearch #BetterScience
FEBS Press
Read the full paper: FEBS Press
doi.org
October 30, 2026 at 7:07 AM
The authors included RRIDs in their in The FEBS Journal paper! Thanks for making your methods matter! #OpenScience #RRID #STMpublishing
FEBS Press
Read the full paper: FEBS Press
doi.org
October 30, 2026 at 7:08 AM
Election Day Distraction: Good news on the dementia front. A drug already OK’d for human safety (for spinal cord injuries) turns out to be Very Promising for treatment of Alzheimer’s.

Yay, Science. Support Basic Science Research.
febs.onlinelibrary.wiley.com/doi/10.1002/...
FEBS Press
Repair of neuronal DNA damage in Alzheimer's disease by KCL-286. (A) Amyloid-β oligomers and plaques impair neuronal DNA repair pathways, leading to DNA double-strand breaks and glial activation. (B)...
febs.onlinelibrary.wiley.com
November 3, 2026 at 6:29 PM
The FEBS Research Academy webpage is now live, introducing its community of 100 Founding Members. 🎉
www.febs.org/other-activi...
October 30, 2026 at 7:51 AM
The authors generated the Graphical Abstract. FEBS Press guidelines state the following: "The use of AI is permitted for the creation of graphical abstracts and covers exclusively to generate illustrations or schematics, not to present data." Thank you for your interest in our society journal!
November 1, 2026 at 12:15 PM
The authors generated the Graphical Abstract. FEBS Press guidelines state the following: "The use of AI is permitted for the creation of graphical abstracts and covers exclusively to generate illustrations or schematics, not to present data." Thank you for your interest in our society journal!
November 1, 2026 at 12:15 PM
🎨Calling all young artists in the scientific community! Our friends at #FEBS are inviting children aged 4–15 to get creative with science through their 𝗖𝗵𝗶𝗹𝗱𝗿𝗲𝗻’𝘀 𝗦𝗰𝗶𝗲𝗻𝗰𝗲 𝗔𝗿𝘁 𝗖𝗼𝗺𝗽𝗲𝘁𝗶𝘁𝗶𝗼𝗻 𝟮𝟬𝟮𝟲!

📅𝗗𝗲𝗮𝗱𝗹𝗶𝗻𝗲: 18 November 2026
October 27, 2026 at 4:07 PM
Day 2 at #FEBSIUBMBENABLE2026 reminded us why science is best done together! 💡

Sometimes one coffee-break conversation can spark new ideas, collaborations and connections. ☕🔬

Take a look at some of our favourite moments! 📸

#FEBS #IUBMB #YoungScientists #ScientificCommunity #Science
October 30, 2026 at 2:30 PM
The latest issue of FEBS Letters is out now! Featuring research and review content on membrane biology and the cytoskeleton, together with our latest The Scientists’ Forum article — where we speak with AIProSaB, a patient advocacy group for people living with progeria.

🔗 tinyurl.com/FEBSL20
October 28, 2026 at 9:20 AM
The authors included RRIDs in their in FEBS Open Bio paper! RRIDs improve reproducibility in scientific research. #accelerateopenscience #reproducibility #OpenScience
Hydrostatic pressure activates HIF‐1α via β‐catenin to promote stemness in breast cancer cells
Read the full paper: Hydrostatic pressure activates HIF‐1α via β‐catenin to promote stemness in breast cancer cells
doi.org
October 30, 2026 at 7:07 AM
RRIDs were included in this in FEBS Open Bio paper. RRIDs improve reproducibility in scientific research. #BetterScience #reproducibility #accelerateopenscience
Dactolisib outperforms Rapamycin in potentiating apoptosis induced by XPO1, Bcl-2 and Mcl-1 blockade in preclinical glioblastoma models
Read the full paper: Dactolisib outperforms Rapamycin in potentiating apoptosis induced by XPO1, Bcl-2 and Mcl-1 blockade in preclinical glioblastoma models
doi.org
October 30, 2026 at 7:07 AM
The authors included RRIDs in their in FEBS Open Bio paper! Thanks for making your methods matter! #accelerateopenscience #BetterScience #reproducibility
The splicing factor DHX38/PRP16 is required for ovarian clear cell carcinoma tumorigenesis, as revealed by a CRISPR‐Cas9 screen
Read the full paper: The splicing factor DHX38/PRP16 is required for ovarian clear cell carcinoma tumorigenesis, as revealed by a CRISPR‐Cas9 screen
doi.org
October 29, 2026 at 7:00 AM
🧬 Looking back at the #FEBSIUBMBENABLE2026 Poster Session!

From sharing exciting research to exchanging ideas and making connections, our poster sessions brought young scientists together for inspiring discussions in Kraków. 🔬✨

#FEBS #IUBMB #PosterSession #YoungScientists #Krakow
October 26, 2026 at 12:30 PM
Spermine is an endogenous small-molecule 20S proteasome activator synergistically coupling chymotrypsin-like active-site modulation with α-ring gate opening
febs.onlinelibrary.wiley.com/doi/10.1111/...
FEBS Press
Spermine activates the 20S proteasome via two kinetically distinct events: selective β5 chymotrypsin-like activation at submillimolar concentrations (Ka = 783 μm) and cooperative α-ring gate opening ....
febs.onlinelibrary.wiley.com
October 24, 2026 at 6:55 AM
Ah, yes, that is the working ultimate causality explanation we are more used to hearing about, but perhaps there are more things dreamt of than that philosophy. Like, say, what if you happened to be a single celled yeast?

febs.onlinelibrary.wiley.com/doi/full/10....
FEBS Press
Apoptosis is a highly regulated form of programmed cell death crucial for life and health in metazoan animals. Apoptosis is defined by a set of cytological alterations. The recent discovery of these ...
febs.onlinelibrary.wiley.com
October 25, 2026 at 3:00 AM
The EACR and The FEBS Journal are collaborating on a Fellowship to offer an EACR member the opportunity to gain experience of scientific publishing through a fellowship with the FEBS journal Molecular Oncology.

Apply by 11 November 2026

https://eacr.org/eacr-molecular-oncology-editorial-fellowship
October 22, 2026 at 12:00 PM
Sign up now for the EMBO | FEBS Lecture Course "Biological surfaces and interfaces: applications, challenges, and opportunities across disciplines" in Sant Feliu de Guixols, Spain, 20–25 Jun 2027.

https://meetings.embo.org/event/27-bio-interfaces
#EMBObioSurfaces #EMBOevents 🧪
Biological surfaces and interfaces: applications, challenges, and opportunities across disciplines
From molecular recognition and cellular communication to interactions with advanced biomaterials, biointerfaces play a fundamental role in life and drive innovation across medicine, biotechnology, an…
meetings.embo.org
October 22, 2026 at 5:20 AM
Febs plan sorted 👌
Gona possibly nip to Liverpool to soak up atmos for an hour or two, then head home, get a juicy take away and watch Dynasty in bed with the floofs.
Perfect Shawn Of The Dead: Perfek
ALT: Perfect Shawn Of The Dead: Perfek
static.klipy.com
October 20, 2026 at 4:59 PM
🎯 We invite you to read the Mini Review in Issue 20 of The FEBS Journal highlighting how targeting LRH-1's tissue-specific pathways could unlock selective, highly targeted therapies for leukemia and immunopathological diseases ➡️ buff.ly/I8gVqJV
#LRH1 #leukemia #immunopathology #nuclearreceptors
October 21, 2026 at 2:09 PM
📣 Congratulations to Zuzana Koskova (@zuzanakoskova.bsky.social ), winner of the FEBS Letters Poster Prize at the EMBO | EMBL Symposium: The complex life of RNA, held in Heidelberg, Germany.

Poster Title: A two-step chromosome-retention mechanism enables pre-rRNA inheritance through mitosis

#RNA
October 20, 2026 at 8:30 AM
RRIDs were included in this in FEBS Open Bio paper. We value the author's support of reproducibility. #accelerateopenscience #STMpublishing #OpenResearch
FEBS Press
Read the full paper: FEBS Press
doi.org
October 16, 2026 at 7:00 AM
The authors included RRIDs in their in Molecular Oncology paper! Thanks for making your methods matter! #OpenScience #accelerateopenscience #STMpublishing
FEBS Press
Read the full paper: FEBS Press
doi.org
October 16, 2026 at 7:00 AM